|
Ferromatik Milacron India Promotes 2 to Leadership Posts
Company veterans Divgi, Bhalavat to help guide ongoing growth
April 18, 2011 – Ferromatik Milacron India Ltd. (FMIL), India’s No. 1 injection
molding machine manufacturer, has promoted two individuals to key leadership
roles as the company continues its rapid growth.
Shirish Divgi is now Chief Operating Officer and Vinod Bhalavat is Chief
Financial Officer of FMIL, a division of Milacron Plastics Machinery. The
promotions correspond with the recent retirement of former FMIL President N.K.
Balgi.
“Divgi and Bhalavat have been instrumental in helping us meet the challenges of
plastics manufacturing customers throughout the growing Indian marketplace,”
said Dave Lawrence, president of Milacron Plastics Machinery. “Their promotions
put both of them in a position to accelerate that success.”
As COO, Divgi will be responsible for Operations, Engineering and Sales &
Marketing. He will report directly to Jay Woerner, Vice President of India
Operations for Milacron Plastics Machinery.
As CFO, Bhalavat will assume responsibility for Finance, Human Resources and
Information Technology. He will report directly to John Francy, Milacron LLC
Chief Financial Officer, and indirectly to Jay Woerner.
Divgi and Bhalavat have been managers at FMIL since the company’s inception in
1995, ensuring a smooth transition.
“We’re grateful for the expertise and leadership Balgi has provided to
Ferromatik India during his tenure as president,” said Lawrence. “I’m personally
pleased that he will remain as a Director of FMIL, so that we can continue to
benefit from his expertise and counsel.”
Milacron Plastics Machinery, a business of Milacron LLC, is a global provider of
advanced injection molding and extrusion processing equipment and services.
Applying deep-rooted industry knowledge built over a century of experience,
Milacron designs, builds and delivers high-performance solutions that help
customers be more efficient, more precise, more productive and more successful.
For more information, visit
www.milacron.com/plastics/
Industry asks DCGI not to amend D&CAct to make 2D barcode
mandatory
The pharma industry in the country, especially the small and medium scale units,
has asked the Drug Controller General of India (DCGI) not to amend the Drug &
Cosmetic Act to make the implementation of2D barcode/UID (Unique Identity Code)
mandatory for the domestic market. Instead of making the 2D barcode/UID
mandatory, the industry asked the DCGI to implement the track and trace system
for which there is already a provision in the Act.
At a meeting convened by the DCGI on the issue recently, the industry is learnt
to have apprised the authorities that as a concept there should be track and
trace of medicines from manufacturing to retail using software system, but
practically it is not possible in India till the time the whole supply chain
along with the manufacturing is automated through web and related software.
The industry also pleaded that as the implementation of the new system involves
an investment of about Rs. 1 to 2 crores. First it should be done on a trial
basis or in stages like the pharma giants who are already using such systems and
share their experience like how effective it is to control spurious drugs and
the cost part of it.
The industry is learnt to have categorically told the authorities that if the
Act is amended to make 2D barcode/UID mandatory in the country, most of the
small and medium companies will have no other option but to shut down as they
will not be able to comply with the new system as the current manpower,
packaging machines, computer hardwares and softwares have to be upgraded and new
equipment to implement 2D and UID have to be purchased involving huge amount.
Ref : Chronical Pharmabiz March 10, 2011 |
